SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE623.303.7 (+0.6 %)
PREV CLOSE ( ) 619.60
OPEN PRICE ( ) 623.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 622.00 (102)
VOLUME 938431
TODAY'S LOW / HIGH ( )619.30 633.25
52 WK LOW / HIGH ( )434.8 633.25
NSE623.503.8 (+0.61 %)
PREV CLOSE( ) 619.70
OPEN PRICE ( ) 623.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 623.50 (13742)
VOLUME 14161255
TODAY'S LOW / HIGH( ) 619.00 633.40
52 WK LOW / HIGH ( )435 633.4
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
16Aug Sun Pharma gets approval from USFDA fo
Sun Pharmaceutical Industries including its subsidiaries and/or associat..
16Aug Sun Pharma gains on getting approval f
Sun Pharmaceutical Industries is currently trading at Rs. 612.25, up by..
14Aug Sun Pharma turns black in Q1FY19
Sun Pharmaceutical Industries has reported results for first quarter end..
07Aug RIL, ONGC and Sun Pharma to see some a
Reliance Industries (RIL)has completed taking 5 percent stake in Eros In..
07Aug Sun Pharma gains on launching Novel Dr
Sun Pharmaceutical Industries is currently trading at Rs. 581.45, up by..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit2593.9-4945.9
Gross Profit 2596 -5199.8
Operating Profit 5375.812510.6
Net Sales 26075.279476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7782.25 (2.87%)
M.Cap (Rs. in Cr)16536.74
Astrazeneca Pharma I (BSE)
 1840.75 (7.63%)
M.Cap (Rs. in Cr)4601.88
Torrent Pharma (BSE)
 1766.70 (3.98%)
M.Cap (Rs. in Cr)29896.58
Alkem Laboratories (BSE)
 2091.95 (2.57%)
M.Cap (Rs. in Cr)25012.40
Coral Laboratories (BSE)
 517.25 (8.67%)
M.Cap (Rs. in Cr)184.79
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 12.64%
MUTUAL FUNDS/UTI 8.5%
FI/BANKS/INSURANCE 8.04%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.